Oxford Tech in £2m round for Lightpoint

Oxford was joined in the round by several angel syndicates, namely Cambridge Capital Group, Envestors, London Business Angels and Ruffena Capital. Equity crowdfunding platform SyndicateRoom also took part in the round.

The company plans on using the funding to finance the introduction of its two lead products, EnLight and LightPath, to the US and UK markets in 2015.

Lightpoint is currently undertaking clinical trials for the use of its technology with stomach, prostate and breast cancer.

Previous funding
Oxford led a £175,000 seed funding round for Lightpoint in June 2013. The firm was joined in the round by Oxford Early Investments, Minerva Business Angels (The University of Warwick Science Park Business Angel Network), the Wroxall Investors Group and several other angel investors.

Company
Founded in 2012, Lightpoint is headquartered in Rickmansworth in Hertfordshire with an additional office in Cambridge, Massachusetts in the US.

The company develops surgical imaging technology based on Cerenkov Luminescence Imaging (CLI), which is designed to reduce the need for repeat operations in cancer patients by detecting cancer in real-time during surgery.

People
David Tuch is chief executive officer of Lightpoint. Lucius Cary is managing director at Oxford Technology.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• UK / Ireland
• Early-stage
• Healthcare
• United Kingdom